Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 290 | 0 | 0 | 0 |
| Gross Profit | 290 | N/A | N/A | N/A |
| Operating Expenses | 7,461 | 5,616 | 5,636 | 0 |
| Operating Income | -7,171 | -5,616 | -5,636 | N/A |
| Other Income | 1 | 3 | 99 | 0 |
| Pre-tax Income | -7,170 | -5,613 | -5,537 | 0 |
| Net Income Continuous | -7,170 | -5,613 | -5,537 | N/A |
| Net Income | $-7,170 | $-5,613 | $-5,537 | $N/A |
| EPS Basic Total Ops | -7.16 | -6.18 | -7.13 | N/A |
| EPS Basic Continuous Ops | -7.16 | -6.17 | -7.13 | N/A |
| EPS Diluted Total Ops | -7.16 | -6.18 | -7.13 | N/A |
| EPS Diluted Continuous Ops | -7.16 | -6.17 | -7.13 | N/A |
| EBITDA(a) | $-6,825 | $-5,350 | $-5,414 | $N/A |